Insider Transactions in Q1 2023 at Tyra Biosciences, Inc. (TYRA)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2023
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
400
-0.08%
|
$6,400
$16.0 P/Share
|
|
Mar 31
2023
|
Daniel Bensen Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+0.08%
|
$0
$0.61 P/Share
|
|
Mar 31
2023
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
500
-0.03%
|
$8,000
$16.05 P/Share
|
|
Mar 31
2023
|
Todd Harris President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+0.03%
|
$1,000
$2.25 P/Share
|
|
Mar 30
2023
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,000
-0.38%
|
$32,000
$16.01 P/Share
|
|
Mar 30
2023
|
Daniel Bensen Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+0.38%
|
$0
$0.61 P/Share
|
|
Mar 30
2023
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
2,407
-0.14%
|
$38,512
$16.02 P/Share
|
|
Mar 30
2023
|
Todd Harris President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,407
+0.14%
|
$4,814
$2.25 P/Share
|
|
Mar 29
2023
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
1,420
-0.08%
|
$22,720
$16.18 P/Share
|
|
Mar 29
2023
|
Todd Harris President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,420
+0.08%
|
$2,840
$2.25 P/Share
|
|
Mar 29
2023
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,187
-0.41%
|
$34,992
$16.21 P/Share
|
|
Mar 29
2023
|
Daniel Bensen Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,187
+0.41%
|
$0
$0.61 P/Share
|
|
Mar 28
2023
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,346
-0.63%
|
$53,536
$16.0 P/Share
|
|
Mar 28
2023
|
Daniel Bensen Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,346
+0.63%
|
$0
$0.61 P/Share
|
|
Mar 28
2023
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
2,779
-0.16%
|
$44,464
$16.0 P/Share
|
|
Mar 28
2023
|
Todd Harris President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,779
+0.16%
|
$5,558
$2.25 P/Share
|
|
Mar 27
2023
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
8,048
-1.5%
|
$128,768
$16.0 P/Share
|
|
Mar 27
2023
|
Daniel Bensen Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,048
+1.48%
|
$0
$0.61 P/Share
|
|
Mar 27
2023
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
2,963
-0.17%
|
$47,408
$16.0 P/Share
|
|
Mar 27
2023
|
Todd Harris President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,963
+0.17%
|
$5,926
$2.25 P/Share
|
|
Mar 24
2023
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
170
-0.01%
|
$2,720
$16.0 P/Share
|
|
Mar 24
2023
|
Todd Harris President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
170
+0.01%
|
$340
$2.25 P/Share
|
|
Mar 23
2023
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,827
-0.91%
|
$77,232
$16.0 P/Share
|
|
Mar 23
2023
|
Daniel Bensen Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,827
+0.9%
|
$0
$0.61 P/Share
|
|
Mar 23
2023
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
2,800
-0.16%
|
$44,800
$16.0 P/Share
|
|
Mar 23
2023
|
Todd Harris President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,800
+0.16%
|
$5,600
$2.25 P/Share
|
|
Mar 22
2023
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,800
-0.71%
|
$60,800
$16.0 P/Share
|
|
Mar 22
2023
|
Daniel Bensen Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,800
+0.71%
|
$0
$0.61 P/Share
|
|
Mar 22
2023
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
4,043
-0.24%
|
$64,688
$16.0 P/Share
|
|
Mar 22
2023
|
Todd Harris President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,043
+0.24%
|
$8,086
$2.25 P/Share
|
|
Mar 21
2023
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
14,100
-2.6%
|
$225,600
$16.0 P/Share
|
|
Mar 21
2023
|
Daniel Bensen Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,100
+2.54%
|
$0
$0.61 P/Share
|
|
Mar 21
2023
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
12,393
-0.72%
|
$198,288
$16.0 P/Share
|
|
Mar 21
2023
|
Todd Harris President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,393
+0.72%
|
$24,786
$2.25 P/Share
|
|
Mar 15
2023
|
Hiroomi Tada Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,893
+2.23%
|
$11,358
$6.58 P/Share
|
|
Mar 15
2023
|
Todd Harris President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,808
+0.11%
|
$10,848
$6.58 P/Share
|
|
Feb 21
2023
|
Piyush R. Patel Chief Development Officer |
SELL
Bona fide gift
|
Direct |
8,442
-10.27%
|
-
|
|
Feb 10
2023
|
Mva Investors, LLC |
SELL
Open market or private sale
|
Direct |
65,568
-74.43%
|
$852,384
$13.4 P/Share
|
|
Feb 09
2023
|
Mva Investors, LLC |
SELL
Open market or private sale
|
Direct |
200,000
-69.42%
|
$2,600,000
$13.1 P/Share
|